Locally Advanced Solid Tumors

Also known as: Locally Advanced Solid Tumor / Locally Advanced Solid Neoplasm

DrugDrug NameDrug Description
DB15685SelpercatinibA RET receptor tyrosine kinase inhibitor for the treatment of RET-driven non-small cell lung cancer, medullary thyroid cancer, and thyroid cancer in appropriate patient populations.
DrugDrug NamePhaseStatusCount
DB12565Abexinostat1Completed1
DB11595Atezolizumab1Recruiting2
DB11666Buparlisib1Recruiting1
DB17465CD-16 NK-92 cells1Active Not Recruiting1
DB00002Cetuximab1Active Not Recruiting1
DB05239Cobimetinib1Active Not Recruiting1
DB00531Cyclophosphamide1Not Yet Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB01248Docetaxel1Recruiting1
DB11986Entrectinib1Completed1
DB01073Fludarabine1Not Yet Recruiting1
DB01073Fludarabine1Recruiting1
DB00441Gemcitabine1Completed1
DB00441Gemcitabine1Recruiting1
DB09035Nivolumab1Completed1
DB01229Paclitaxel1Completed1
DB01229Paclitaxel1Recruiting1
DB09037Pembrolizumab1Completed1
DB09037Pembrolizumab1Not Yet Recruiting1
DB09037Pembrolizumab1Recruiting2
DB14904Pimasertib1Completed1
DB18428RC1181Completed1
DB16826Repotrectinib1Withdrawn1
DB15766Retifanlimab1Active Not Recruiting1
DB12400Voxtalisib1Completed1
DB11885Anlotinib1 / 2Recruiting1
DB17399JBI-8021 / 2Recruiting1
DB13982Lutetium Lu-1771 / 2Recruiting1
DB18682NVL-6551 / 2Recruiting1
DB18289OBI-8881 / 2Terminated1
DB17356OBI-9991 / 2Terminated1
DB09330Osimertinib1 / 2Recruiting1
DB09037Pembrolizumab1 / 2Recruiting2
DB16826Repotrectinib1 / 2Recruiting2
DB17411TNG9081 / 2Recruiting1
DB01101Capecitabine2Active Not Recruiting1
DB11793Niraparib2Active Not Recruiting1
DB09567Olive oil2Active Not Recruiting1
DB00526Oxaliplatin2Active Not Recruiting1
DB00526Oxaliplatin2Not Yet Recruiting1
DB09037Pembrolizumab2Recruiting1
DB11857Seribantumab2Active Not Recruiting1
DB15765Sintilimab2Not Yet Recruiting1
DB15043Toripalimab2Active Not Recruiting1
DB00072Trastuzumab2Not Yet Recruiting1